About This Reference Desk

What Highlander Peptide is

Highlander Peptide is an independent editorial reference desk covering the published research on two compounds studied in the context of longevity and cellular health: Epitalon and NAD+. The site exists to make a frequently overstated, unevenly replicated, and commercially noisy literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species and model system, and how far that evidence honestly reaches.

The organizing frame is telomere and pineal geroprotection. Epitalon sits at the intersection of those two axes — proposed telomerase upregulation and pineal melatonin normalization. NAD+ sits at the metabolic axis of aging — the central cellular coenzyme whose age-related decline has generated the field's largest body of human trial evidence. Each compound has its own dedicated page; a comparison page lines them up on the dimensions that matter for reading research; and a single shared references list aggregates every source cited on the site.

The editorial standard is evidence quality at its actual grade. Where a claim is from cell culture, this desk says cell culture. Where it is a mouse result, it says mouse result. Where the human data are observational without a placebo arm, it says so plainly. Where an independent replication now exists that didn't before, that is noted too — as a genuine advance, not minimized, but also not extrapolated beyond what it shows. The site does not cherry-pick favorable results or suppress inconvenient caveats; the caveats are the point.

How it is compiled

Three principles govern what appears on this site.

First, everything is anchored to peer-reviewed sources. Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed links — collected in full on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such, and where the review itself draws conclusions that differ from the underlying papers, this desk notes the distinction.

Second, evidence is reported at its actual strength. Study doses are given in the species, route, and concentration in which they were used — for example, "1.0 ug/mouse subcutaneously in female SHR mice" — never scaled to humans or offered as a recommendation. Where the evidence is preclinical, originating from a single laboratory, or uses a different compound from the one being marketed (as with epithalamin versus Epitalon), the page says so directly. That precision is not hedging — it is the core purpose of the site.

Third, context is carried forward across pages. Because the same mechanisms — telomerase, sirtuins, CD38, melatonin — recur in both research areas, the compound pages cross-reference each other where the biology overlaps, so a reader can trace a mechanism across the two entries rather than treating each page as a silo.

What it is not

Highlander Peptide is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any compound or research chemical, and it has no affiliate or referral relationship with any vendor or IV-therapy provider. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, cycle length, or route of administration for any person — not even informally, and not by implication.

The compounds discussed here differ in regulatory status: Epitalon is a research chemical with no approved human use in major Western markets; NAD+ precursors are marketed as dietary supplements, with compounded injectable forms carrying additional regulatory and safety complexity. Neither of these facts makes either compound a medicine for any aging-related condition; neither is presented here as one. Readers interested in any condition described in the underlying research should consult a licensed clinician working with regulated, evidence-based options. The aim of this site is accuracy about what the science says — nothing more, and nothing it pretends to be.